THE government has secured a supply of new vaccines protecting against four strains of influenza virus for the 2017 season.
GlaxoSmithKline, Sanofi and Seqirus have been announced as suppliers, with four age-specific vaccines available under the National Immunisation Program: Fluarix Tetra, FluQuadri, FluQuardi Junior and Afluria Quad.
About 4.5 million doses will be made available in 2017 via the NIP.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 17
